EGFR Fc Chimera Protein 344-ER-050 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemEGFR Fc Chimera Protein
CompanyR&D Systems, a Bio-Techne Brand
Price Pricing Info Supplier Page View Company Product Page
Catalog Number344-ER-050
FormatLyophilized from a 0.2 µm filtered solution in PBS
SpeciesHuman
Quantity50 ug
Molecule NameEGFR
NCBI Full Gene Nameepidermal growth factor receptor
NCBI Gene AliasesERBB, ERBB1, ERRP, HER1, NISBD2, PIG61, mENA
Purity>90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining
Molecular WeightObserved: 125-145 kDa, under reducing conditions.
Theoretical: 95.1 kDa (monomer)
Brand/TrademarkR&D Systems, a Bio-Techne Brand
ApplicationsBinding Activity
Conjugate/TagUnconjugated
Source/Expression SystemNS0-derived Recombinant Human EGFR Fc Chimera Protein
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution

Specifications/Features

Available conjugates: Unconjugated

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) Format chain exchange (FORCE) for high-throughput generation of bispecific antibodies in combinatorial binder-format matricesNature communicationsOctober 2, 2020Dengl S, Mayer K, Bormann F, Duerr H, Hoffmann E, Nussbaum B, Tischler M, Wagner M, Kuglstatter A, Leibrock L, et al.

(2) Antibody-like proteins that capture and neutralize SARS-CoV-2Science advancesOctober 1, 2020Kondo T, Iwatani Y, Matsuoka K, Fujino T, Umemoto S, Yokomaku Y, Ishizaki K, Kito S, Sezaki T, Hayashi G, et al.

(3) Design Strategy to Create Antibody Mimetics Harbouring Immobilised Complementarity Determining Region Peptides for Practical UseScientific reportsJanuary 21, 2020Kadonosono T, Yimchuen W, Ota Y, See K, Furuta T, Shiozawa T, Kitazawa M, Goto Y, Patil A, Kuchimaru T, et al.

(4) Cancer Immunotherapy with T Cells Carrying Bispecific Receptors That Mimic AntibodiesCancer immunology researchMay 1, 2019Ahn S, Li J, Sun C, Gao K, Hirabayashi K, Li H, Savoldo B, Liu R, Dotti G.

(5) Modified aptamers enable quantitative sub-10-nm cellular DNA-PAINT imagingNature MethodsSeptember 1, 2018Sebastian Strauss, Philipp C. Nickels, Maximilian T. Strauss, Vilma J. Jimenez Sabinina, Jan Ellenberg, Jeffrey D. Carter, Shashi Gupta, Nebojsa Janjic, Ralf Jungmannaptamers were measured in solution at 37°C as described in Gold et al., 201023. Recombinant EGFR (cat: 344-ER-050), GFP_AEQVI (cat:14392), and Catalase (cat: 16-05-030000) proteins were purchased from R&D Systems,

(6) Recombinant phosphatidylserine-binding nanobodies for targeting of extracellular vesicles to tumor cells: a plug-and-play approachNanoscaleFebruary 1, 2018Kooijmans SAA, Gitz-Francois JJJM, Schiffelers RM, Vader P.

(7) The S100A4 Protein Signals through the ErbB4 Receptor to Promote Neuronal SurvivalTheranosticsJanuary 1, 2018Pankratova S, Klingelhofer J, Dmytriyeva O, Owczarek S, Renziehausen A, Syed N, Porter AE, Dexter DT, Kiryushko D.

(8) A High-Affinity Repebody for Molecular Imaging of EGFR-Expressing Malignant TumorsTheranosticsJune 25, 2017Misun Yun et al.

(9) Heterobifunctional Dyes: Highly Fluorescent Linkers Based on Cyanine DyesChemistryOpenJune 1, 2017Wycisk V, Achazi K, Hirsch O, Kuehne C, Dernedde J, Haag R, Licha K.

(10) A derivative of platelet-derived growth factor receptor alpha binds to the trimer of human cytomegalovirus and inhibits entry into fibroblasts and endothelial cellsPLoS pathogensApril 1, 2017Stegmann C, Hochdorfer D, Lieber D, Subramanian N, Stöhr D, Laib Sampaio K, Sinzger C.

(11) A Highly Diverse and Functional Naïve Ubiquitin Variant Library for Generation of Intracellular Affinity ReagentsJournal of molecular biologyJanuary 6, 2017Leung I, Jarvik N, Sidhu SS.

(12) Masked Chimeric Antigen Receptor for Tumor-Specific ActivationMolecular therapy : the journal of the American Society of Gene TherapyJanuary 4, 2017Han X, Bryson PD, Zhao Y, Cinay GE, Li S, Guo Y, Siriwon N, Wang P.

(13) A Novel Bispecific Antibody Targeting EGFR and cMet Is Effective against EGFR Inhibitor-Resistant Lung TumorsCancer researchJuly 1, 2016Moores SL, Chiu ML, Bushey BS, Chevalier K, Luistro L, Dorn K, Brezski RJ, Haytko P, Kelly T, Wu SJ, et al.

(14) A HER2-specific Modified Fc Fragment (Fcab) Induces Antitumor Effects Through Degradation of HER2 and ApoptosisMolecular therapy : the journal of the American Society of Gene TherapyNovember 1, 2015Leung KM, Batey S, Rowlands R, Isaac SJ, Jones P, Drewett V, Carvalho J, Gaspar M, Weller S, Medcalf M, et al.

(15) Design of an optimized scaffold for affibody moleculesJournal of molecular biologyApril 30, 2010Feldwisch J, Tolmachev V, Lendel C, Herne N, Sjöberg A, Larsson B, Rosik D, Lindqvist E, Fant G, Höidén-Guthenberg I, et al.

Be the First to Write a Review!

EGFR Fc Chimera Protein

EGFR Fc Chimera Protein

EGFR Fc Chimera Protein

EGFR Fc Chimera Protein

EGFR Fc Chimera Protein from R&D Systems, a Bio-Techne Brand

Description

Specifications/Features

R&D Systems, a Bio-Techne Brand

Citations (15)

Reviews

EGFR Fc Chimera Protein from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map